The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tirofiban Hydrochloride
Tirofiban Hydrochloride · TIROFIBAN HYDROCHLORIDE .25 mg/mL · Injection · Amdipharm Limited
NDC 82169-0025-50 · 48 VIAL, GLASS in 1 CASE / 50 mL in 1 VIAL, GLASS · EXPORT ONLY · View full market →
Medicare Part D
This product is labeled for export only and is not sold to US patients, so Medicare does not price it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Tirofiban Hydrochloride (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amdipharm Limited | TIROFIBAN HYDROCHLORIDE .25 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Nexus Pharmaceuticals LLC | TIROFIBAN HYDROCHLORIDE 50 ug/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Tirofiban Hydrochloride — NDC 82169-0025-50," retrieved September 3, 2026, https://drugdashboards.com/drug/82169002550.
Free to cite with attribution — see how the data is put together.